Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 10.06.2026, 23:17:09
283,10 DKK
Kurs
Kurs
5,05%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
533,40 DKK
52 Wochen Hoch
52 Wochen Hoch
- Eher Negativ
- Seit dem 02.06.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 290 | 283,10 | 290 | 2,437301 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 283,10 305 | 283,10 | 305 | 7,735782 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 290 | 283,10 | 290 | 2,437301 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 290 | 283,10 | 290 | 2,437301 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 283,10 300 | 283,10 | 300 | 5,969622 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 283,10 175 | 283,10 | 175 | 38,184387 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 290 | 283,10 | 290 | 2,437301 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 290 | 283,10 | 290 | 2,437301 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 283,10 | 283,10 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 283,10 300 | 283,10 | 300 | 5,969622 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 283,10 332 | 283,10 | 332 | 17,273048 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 283,10 263 | 283,10 | 263 | 7,099965 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 283,10 175 | 283,10 | 175 | 38,184387 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 283,10 300 | 283,10 | 300 | 5,969622 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 275 | 283,10 | 275 | 2,86118 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 283,10 332 | 283,10 | 332 | 17,273048 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 283,10 263 | 283,10 | 263 | 7,099965 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 283,10 275 | 283,10 | 275 | 2,86118 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 283,10 300 | 283,10 | 300 | 5,969622 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 283,10 260 | 283,10 | 260 | 8,159661 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 283,10 400 | 283,10 | 400 | 41,292829 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 283,10 400 | 283,10 | 400 | 41,292829 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 283,10 332 | 283,10 | 332 | 17,273048 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 283,10 340 | 283,10 | 340 | 20,098905 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 283,10 275 | 283,10 | 275 | 2,86118 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 283,10 340 | 283,10 | 340 | 20,098905 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 283,10 275 | 283,10 | 275 | 2,86118 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 283,10 250 | 283,10 | 250 | 11,691982 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 283,10 340 | 283,10 | 340 | 20,098905 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 283,10 340 | 283,10 | 340 | 20,098905 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 283,10 340 | 283,10 | 340 | 20,098905 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 283,10 340 | 283,10 | 340 | 20,098905 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 283,10 400 | 283,10 | 400 | 41,292829 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 283,10 275 | 283,10 | 275 | 2,86118 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 283,10 332 | 283,10 | 332 | 17,273048 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 283,10 475 | 283,10 | 475 | 67,785235 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 283,10 332 | 283,10 | 332 | 17,273048 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 283,10 390 | 283,10 | 390 | 37,760509 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 283,10 436 | 283,10 | 436 | 54,009184 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 283,10 415 | 283,10 | 415 | 46,59131 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 283,10 390 | 283,10 | 390 | 37,760509 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 283,10 390 | 283,10 | 390 | 37,760509 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 283,10 415 | 283,10 | 415 | 46,59131 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 283,10 475 | 283,10 | 475 | 67,785235 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 283,10 390 | 283,10 | 390 | 37,760509 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 283,10 400 | 283,10 | 400 | 41,292829 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 283,10 400 | 283,10 | 400 | 41,292829 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 283,10 360 | 283,10 | 360 | 27,163546 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 283,10 475 | 283,10 | 475 | 67,785235 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 283,10 475 | 283,10 | 475 | 67,785235 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 283,10 295 | 283,10 | 295 | 4,203462 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 283,10 295 | 283,10 | 295 | 4,203462 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 283,10 350 | 283,10 | 350 | 23,631226 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 283,10 352 | 283,10 | 352 | 24,33769 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 283,10 400 | 283,10 | 400 | 41,292829 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 283,10 295 | 283,10 | 295 | 4,203462 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 283,10 270 | 283,10 | 270 | 4,62734 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 283,10 375 | 283,10 | 375 | 32,462028 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 283,10 315 | 283,10 | 315 | 11,268103 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M